Lawsuit Demands FDA Take Dangerous Abortion Pills Off the Market

FOR IMMEDIATE RELEASE: November 18, 2022

Contact: Mary Owens, [email protected]

Rate of Chemical Abortion-Related ER Visits Has Increased Over 500% Since Mifepristone Approved

Washington, D.C.In response to Alliance Defending Freedom bringing a lawsuit against the U.S. Food and Drug Administration for their reckless and inadequate screening of the dangerous abortion drug regimen of mifepristone and misoprostol, the national pro-life group Susan B. Anthony Pro-Life America issued the following statement:   

“First authorized in 2000 and expanded via mail-order under the pro-abortion Biden administration, abortion pills are swiftly becoming a leading health risk to mothers and babies. The FDA’s reckless lack of meaningful oversight has led to serious complications and a surge in emergency room visits for women using this drug regimen,” said SBA Pro-Life America President Marjorie Dannenfelser. “Pregnancy is not an ‘illness’ as the FDA described in their creative justification to broadly distribute this dangerous pill. We thank Alliance Defending Freedom for bringing this lawsuit against the FDA, and we hope to soon see these dangerous pills taken off the market.”

If granted, the injunction will not prevent state-level safeguards, nor will it impact standard medical treatment for miscarriage or ectopic pregnancy.

Charlotte Lozier Institute President Chuck Donovan added:

“Over 20 years ago, the FDA yielded to political pressure and bypassed their own safety regulations and requirements to allow distribution of mifepristone, which almost immediately proved dangerous due to lethal infections.

“Despite comprehensive data from both the United States and Europe on higher rates of complications and a 500% increase in the rate of abortion pill-related emergency room visits, the FDA until now has remained asleep at the switch. I am grateful for ADF’s leadership in challenging the FDA on their profoundly anti-woman and anti-family handling of mifepristone.”

In April 2021, the FDA announced it was suspending the in-person dispensing requirement for mifepristone under the guise of the COVID-19 emergency. In December 2021, the FDA decided to permanently allow abortion by mail.

Multiple peer-reviewed studies confirm that women are at risk of severe side effects after taking chemical abortion pills, including hemorrhaging, the need for follow-up surgery, and even death. New Lozier Institute peer-reviewed research has found women are also twice as likely to be admitted for surgery if their abortion pill-related complications are miscoded by emergency room personnel as a natural miscarriage.

Susan B. Anthony Pro-Life America is a network of more than one million pro-life Americans nationwide, dedicated to ending abortion by electing national leaders and advocating for laws that save lives, with a special calling to promote pro-life women leaders.


Share this article: